AngioDynamics Will Acquire Vortex Medical; Sees Deal Hurting EPS $0.09 GAAP 2013

AngioDynamics ANGO, a leading provider of innovative minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it has entered into a definitive agreement to acquire all the outstanding capital stock of Vortex Medical Inc., a privately-held company focused on the development of innovative medical devices for the removal of thrombus, or blood clots, from occluded blood vessels.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!